002246SZSE

2025 Annual Report of Independent Director (Xiao Zhongliang)

✨ AI Summary

This report outlines the performance of independent director Xiao Zhongliang for 2025, emphasizing adherence to legal regulations and active participation in board meetings. Xiao attended all required meetings, supported all proposals, and maintained independence without conflicts of interest. Key decisions included the appointment of senior management, ensuring compliance with governance standards, and fostering communication with shareholders.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

2025 Annual Report of Independent Director

As an independent director of North Chemical Industry Co., Ltd. (hereinafter referred to as "the Company"), I, Xiao Zhongliang, have diligently fulfilled my responsibilities in 2025 in accordance with the Company Law, Securities Law, Management Measures for Independent Directors of Listed Companies, Shenzhen Stock Exchange Listing Rules, and relevant regulations. I have actively engaged in understanding the Company's operations and development, attended board and shareholder meetings, participated in significant decisions, and provided independent and objective opinions to protect the overall interests of the Company and the legitimate rights of all shareholders. Below is my performance report for 2025:

1. Basic Information of the Independent Director

Xiao Zhongliang: Chinese nationality, male, Han ethnicity, born in February 1957, holds a doctoral degree, and has no permanent residency abroad. Currently, I am a second-level professor and doctoral supervisor at Nanjing University of Science and Technology, an independent director of Shenzhen Jinaobo Technology Co., Ltd., and an independent director of North Chemical Industry Co., Ltd.

2. Overview of Independent Director's Annual Performance

(1) Meeting Attendance

In 2025, the Company held 9 board meetings and 4 shareholder meetings. My attendance record is as follows:

Meeting TypeTotal Meetings RequiredIn-Person AttendanceAttendance by CommunicationProxy AttendanceAbsencesConsecutive AbsencesShareholder Meeting Attendance
Board Meeting11000No1

In 2025, I also served as the convener of the sixth Nomination Committee and a member of the Compensation and Assessment Committee. My attendance at these meetings is as follows:

Meeting NameTotal Meetings RequiredIn-Person AttendanceProxy AttendanceAbsences
Nomination Committee1100
Compensation Committee1100

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.